Dr. Brad Bower is an NIH Data and Technology Advancement (DATA) National Service Scholar at NIBIB. His project includes identifying and advancing opportunities for interoperability across NIH repositories, including the Medical Imaging and Data Resource Center (MIDRC) at NIBIB, the National COVID Cohort Collaborative (N3C) at the National Center for Advancing Translational Sciences (NCATS), and BioData Catalyst at the National Heart, Lung, and Blood Institute (NHLBI). Additional goals of the project include exploring public-private partnerships in the data ecosystem and promoting the bench-to-bedside data lifecycle for artificial intelligence (AI) product development to lower the barriers to commercialization of new AI-based products.
Dr. Bower has a diverse set of experiences in research, marketing, and leadership roles in medical device companies, ranging from preclinical research and development to clearance from the U.S. Food and Drug Administration (FDA), along with product launch and post-market activities. His prior work includes ophthalmic imaging devices, non-invasive concussion diagnostics, point-of-care diagnostics, and AI-enabled magnetic resonance imaging (MRI)-based predictors for autism spectrum disorder in infants.